Advanced company searchLink opens in new window

ENVISION PHARMA GROUP LIMITED

Company number 10117262

Filter by category

Filter by category


Confirmation statement filters

Company Results (links open in a new window)
Date (document was filed at Companies House) Type Description (of the document filed at Companies House) View / Download (PDF file, link opens in new window)
26 Apr 2022 SH01 Statement of capital following an allotment of shares on 30 June 2021
  • USD 155,644,995.098
17 Feb 2022 AAMD Amended group of companies' accounts made up to 31 December 2020
12 Jan 2022 TM01 Termination of appointment of Andrea Ponti as a director on 14 December 2021
12 Jan 2022 TM01 Termination of appointment of Gregory Spencer Caswill as a director on 14 December 2021
12 Jan 2022 TM01 Termination of appointment of Mike Mortimer as a director on 14 December 2021
12 Jan 2022 TM01 Termination of appointment of Brian Alexander Hepburn as a director on 14 December 2021
11 Jan 2022 AP01 Appointment of Mr Joshua Hollis Korth as a director on 14 December 2021
07 Jan 2022 AA Group of companies' accounts made up to 31 December 2020
24 Sep 2021 TM01 Termination of appointment of Joseph Christopher Brown as a director on 23 June 2021
24 Sep 2021 TM01 Termination of appointment of John David Gillie as a director on 10 August 2021
05 May 2021 CS01 Confirmation statement made on 10 April 2021 with updates
05 May 2021 PSC02 Notification of Evidence Midco Limited as a person with significant control on 4 November 2020
05 May 2021 PSC09 Withdrawal of a person with significant control statement on 5 May 2021
15 Dec 2020 AP01 Appointment of Mr Andrea Ponti as a director on 4 November 2020
26 Nov 2020 TM01 Termination of appointment of Benjamin Maurice Frederick Witcher as a director on 4 November 2020
26 Nov 2020 TM01 Termination of appointment of Bruno Serge Leon Ladriere as a director on 4 November 2020
26 Nov 2020 TM01 Termination of appointment of Daniel Jacques Joseph Alexandre Setton as a director on 4 November 2020
25 Nov 2020 MA Memorandum and Articles of Association
25 Nov 2020 RESOLUTIONS Resolutions
  • RES10 ‐ Resolution of allotment of securities
  • RES01 ‐ Resolution of Memorandum and/or Articles of Association
24 Nov 2020 SH01 Statement of capital following an allotment of shares on 10 November 2020
  • USD 155,644,995.178
04 Nov 2020 SH01 Statement of capital following an allotment of shares on 4 November 2020
  • USD 155,644,995.078
26 Oct 2020 RP04CS01 Second filing of Confirmation Statement dated 10 April 2020
26 Oct 2020 RP04CS01 Second filing of Confirmation Statement dated 10 April 2018
26 Oct 2020 RP04CS01 Second filing of Confirmation Statement dated 10 April 2019
24 Oct 2020 RP04CS01 Second filing of Confirmation Statement dated 10 April 2017